startups digital health weight loss glp-1 Riding the Wegovy wave: The shifting focus to GLP-1s to tap the $150bn drug market These weight-loss startups tell customers
Description
References Moiz A, Filion KB, Tsoukas MA, Yu OH, Peters TM, Eisenberg MJ
These results are based on 22 comparisons for HHF and 18 comparisons for the renal outcome

Note: qd: once a day

[DOI] [PubMed] [Google Scholar] 23.Kaihara K.A., Dickson L.M., Jacobson D.A., Tamarina N., Roe M.W., Philipson L.H., Wicksteed B

Licensed providers determine which option is clinically appropriate based on your individual situation
